Baoyang Pharmaceutical (301015.SZ) is planning to issue H-shares and list them on the stock market.

Zhixin Finance and Economics APP news, Baiyang Medicine (301015.SZ) announced that, in order to further enhance the company's capital strength and overall competitiveness, deepen the company's globalization development strategy and overseas business layout, enhance brand influence and core competitiveness, consolidate its leading position in the industry, fully leverage the resources and advantages of the international capital market, optimize the capital structure, broaden diversified financing channels, and comprehensively enhance the company's comprehensive strength, the company plans to publicly issue H shares and list on the Main Board of the Stock Exchange Limited (hereinafter referred to as the "Hong Kong Stock Exchange") in Hong Kong.